Clinical Course and Modern Diagnosis of Resistant Forms of Pulmonary Tuberculosis

Authors

  • Jumaev M. F Bukhara State Medical Institute
  • Usmonov I. Kh. Bukhara State Medical Institute

DOI:

https://doi.org/10.31150/ajshr.v3i2.879

Keywords:

resistant form of tuberculosis, pulmonary tuberculosis, clinical course, diagnosis, treatment

Abstract

A survey of 244 patients from the southern regions of the Republic of Uzbekistan was carried out in the period from 2016 to 2020. The age of patients ranged from 18 to 86 years, the average age was 52.1 years, men were 2.2 times more than women. The localization of the tuberculous process in most patients was observed on both lungs - in 89 (36.5%), in 86 (35.2%) - damage to the right lung and less cases of the left lung - in 69 (28.3%) patients. It should be noted that a total lesion of one lung was observed in 51 (20.9%) cases, and a total lesion of both lungs - in 29 (11.9%) patients in whom the clinical manifestation of the disease was severe. Out of 244 patients, in 151 (61.9%) patients, the disease was detected for the first time, and in 93 (38.1%) - again, i.e. they have previously received treatment.

In 239 (97.9%) cases, pulmonary tuberculosis was established by X-ray methods, and the X-ray symptom "Periscissuritis" was often observed - in 74.6% of cases.

Bacterioscopy examination revealed MBT in 154 (63.1%) cases, and 90 (36.9%) cases of MBT were not detected. Sowing of pathological material was carried out on the solid medium of Levenshtein-Jensen - in 229 (93.9%) patients and in 206 (89.9%) cases, growth of colonies of Mycobacterium tuberculosis was noted. And the liquid medium BACTEC MGite 960 - in 15 (6.1%) cases and 11 (73.3%) cases, a positive result was obtained. PCR diagnostics was carried out in the Gene / Xpert device - in 244 (100%) patients and 237 (97.1%) cases, DNA of mycobacterium tuberculosis was detected, and in the HAINtest device - in 164 (67.2%) cases and 100% of cases positive result.

References

Aslonov F.I, Rustamova S.A., Raxmonova K.M. Immunopatological aspects in patients with first detected pulmonary tuberculosis // World Bulletin of Public Health. Vol. 4 (2021). P. 91-95.

Federal Clinical Guidelines for the Diagnosis and Treatment of Multidrug and Extensively Drug-Resistant Respiratory Tuberculosis. - M., 2015. - 52 p.

Isomiddin Kh. Usmonov, Bahodir R. Muazzamov, Muhtor F. Jumaev. Features of diagnostics and treatment of drug-resistant forms of pulmonary tuberculosis// International Journal of Pharmaceutical Research | Jan - Mar 2021 | Vol 13 | Issue 1, R. 2484-2489.

Isomiddin Usmonov, Umrzok Shukurov. Features of the clinical course, the state of diagnosis and treatment of hiv-associated pulmonary tuberculosis in modern conditions. Literature review// Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue 4, 2021, Pages. 1809 - 1828.

Isomiddin Xaydarovich Usmonov, Nodir Yusufovich Kobilov. Epidemiology, clinical course, diagnosis and treatment of generalized tuberculosis in modern circumstances. Literature Review// Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue 2, 2021, Pages. 3806 - 3819.

Kenzhaeva Nozima Akhtamovna. Pulmonary tuberculosis and mental disorders// New day in medicine, 2 (34) 2021, Pages 273-275.

Myakisheva T.V. Features of the course and effectiveness of treatment of pulmonary tuberculosis with drug resistance of the pathogen in young people// Abstract of diss. for the degree of Doctor of Medical Sciences / Moscow. – 2013. S. 39-41.

Nikolaeva S.V. The effectiveness of the treatment of patients with pulmonary tuberculosis with multidrug-resistant mycobacteria in the Republic of Buryatia / Bulletin of the All-Russian Scientific Center of the Siberian Branch of the Russian Academy of Medical Sciences, 2012, 5 (87). Part 1.- S. 375-378. 69

Pranger A. D. et al. The role of fluoroquinolones in the treatment of tuberculosis in 2019 // Drugs. Springer International Publishing. ‒ 2019. ‒ Vol. 79, No. 2. - P. 161-171.

Punga V.V., Rusakova L.I., Puzanov V.A. et al.. The prevalence of drug-resistant tuberculosis // Tuberculosis and lung diseases. -2011. – No. 10. – P. 6–15.

Rakhmonova Kamola Mizrobovna. Pulmonary tuberculosis and concomitant diseases// Central Asian journal of medical and natural sciences, Volume: 02 Issue: 06 | Nov-Dec 2021 ISSN: 2660-4159, Pages 137-144.

Russkikh A. E., Kutuzova D. M., Lovacheva O. V., Samoilova A. G., Vasilyeva I. A. Short-term regimens for the treatment of patients with multidrug-resistant tuberculosis. Current situation and future prospects // Tuberculosis and lung diseases. - 2020. - T. 98, No. 12. - S. 57-66.

WHO Consolidated guidelines on tuberculosis, Module 4: treatment ‒drug-resistant tuberculosis treatment [Electronic resource]. URL: https://www.who.int/publications/i/item/9789240007048 (accessed: 08/05/2020).

WHO guidelines for the treatment of drug-resistant tuberculosis: Per. from English. - WHO, Geneva. – 2016.

Харибова Е. А., Тешаев Ш. Ж. Морфофункциональные особенности тканевой организации энтероэндокринных клеток в возрастном аспекте //Проблемы биологии и медицины. – 2020. – №. 2. – С. 168-173.

Ilkhomovna K. D. Morphological Features of Tumor in Different Treatment Options for Patients with Locally Advanced Breast Cancer //International Journal of Innovative Analyses and Emerging Technology. – 2021. – Т. 1. – №. 2. – С. 4-5.

Khodjayeva D. I. MORPHOLOGY OF IDIOPATHIC SCOLIOSIS BASED ON SEGMENT BY SEGMENT ASSESSMENT OF SPINAL COLUMN DEFORMITY //Scientific progress. – 2022. – Т. 3. – №. 1. – С. 208-215.

Downloads

Published

2022-02-22

How to Cite

M. F, J. ., & I. Kh., U. . (2022). Clinical Course and Modern Diagnosis of Resistant Forms of Pulmonary Tuberculosis. American Journal of Social and Humanitarian Research, 3(2), 250–260. https://doi.org/10.31150/ajshr.v3i2.879

Issue

Section

Articles

Similar Articles

<< < 1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.